PR83971

SOMERSET, N.J., May 21, 2020 /PRNewswire=KYODO JBN/ --

Catalent (NYSE:CTLT), a global leader in clinical supply services, today

announced a deal to acquire a clinical packaging facility in Minakuchi, located

in the Shiga prefecture of Japan, from Teva-Takeda Pharmaceuticals. This

purchase will establish a new clinical GMP manufacturing and distribution hub

to support clinical studies. Financial details of the deal, which is expected

to close on July 1, 2020, have not been disclosed.

The approximately 60,000-square-foot facility will be the largest in the

company's Asia Pacific clinical supply network. The new facility will offer

customers access to Catalent's FastChain® demand-led supply services, primary

and secondary packaging capabilities, a range of temperature options for

storage and distribution, as well as clinical returns and destruction services.

It will operate in partnership with Catalent's existing Japanese clinical

supply facility at Kakegawa, serving both local customers as well as global

biotech and pharmaceutical companies.

"This new facility provides much-needed capacity as we look to expand our

capabilities across the Asia-Pacific region, and follows on from recent

expansions and investments we have made in our clinical supply business in

China and Singapore," commented Ricci Whitlow, President, Catalent Clinical

Supply Services. "Our strategy has been to build expertise and capacity in this

region as demand for local clinical supply services increases, to provide

support to customers with global programs, and to meet the growing demand in

biologics and cell and gene therapy studies."

With sites in the U.S., U.K., Germany, Singapore, Japan and China, and an

extended network of over 50 depots, Catalent's clinical supply services can

handle a broad range of international compliance and distribution requirements

to support global clinical trials.

For further information on Catalent's Clinical Supply Services business visit

https://www.clinical.catalent.com.

Notes for Editors

About Catalent Clinical Supply Services

Catalent is a global leader in clinical supply services, with comprehensive and

flexible solutions for small molecules, biologics, and cell and gene therapies

and integrated solutions to accelerate speed to clinic. Catalent offers a full

range services including clinical supply management, comprehensive packaging

solutions, comparator sourcing, cold chain storage and global distribution and

specialized supply chain services including direct-to-patient and demand-led

supply. With nine GMP clinical packaging facilities and over 50 strategically

located depots on six continents combined with more than 25 years' experience

across thousands of studies in more than 80 countries, Catalent has the

comprehensive services, global scale and expertise necessary to reliably supply

clinical trials of all sizes and complexity anywhere in the world.

About Catalent

Catalent is the leading global provider of advanced delivery technologies,

development, and manufacturing solutions for drugs, biologics, cell and gene

therapies, and consumer health products. With over 85 years serving the

industry, Catalent has proven expertise in bringing more customer products to

market faster, enhancing product performance and ensuring reliable global

clinical and commercial product supply. Catalent employs over 13,500 people,

including over 2,400 scientists and technicians, at more than 40 facilities,

and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent

is headquartered in Somerset, New Jersey.

For further  information on Catalent, please visit www.catalent.com.

More products. Better treatments. Reliably supplied.(TM)

SOURCE: Catalent

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=363659

   Caption: Catalent new acquired clinical packaging facility located in the Shiga

prefecture of Japan